Cite
APA Citation
Fitz-Patrick, D., Roberson, K., Niwa, K., Fujimura, T., Mori, K., Hall, J., Yan, X., Shen, Z., Liu, S., Ito, Y., & Baumgartner, S. (2019). safety and efficacy of verinurad, a selective URAT1 inhibitor, for the treatment of patients with gout and/or asymptomatic hyperuricemia in the United States and Japan: Findings from two phase II trials. Modern rheumatology, 29(6), 1042–1052. http://access.bl.uk/ark:/81055/vdc_100099954089.0x00003b